These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 191546)
1. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1. Williams BB; Bailey EJ; Lerner AM J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546 [TBL] [Abstract][Full Text] [Related]
2. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. Champney KJ; Lauter CB; Bailey EJ; Lerner AM J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024 [TBL] [Abstract][Full Text] [Related]
3. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine. Smith SH; Shipman C; Drach JC Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine. Kufe D; Herrick D; Crumpacker C; Schnipper L Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173 [TBL] [Abstract][Full Text] [Related]
5. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. Plunkett W; Cohen SS Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity. Schwartz PM; Novack J; Shipman C; Drach JC Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Shipman C; Smith SH; Carlson RH; Drach JC Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. White EL; Shaddix SC; Brockman RW; Bennett LL Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080 [TBL] [Abstract][Full Text] [Related]
9. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase. Helland S; Ueland PM Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor. Falcon MG; Jones BR J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor. Schwartz PM; Shipman C; Drach JC Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947 [TBL] [Abstract][Full Text] [Related]
12. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Müller WE; Rohde HJ; Beyer R; Maidhof A; Lachmann M; Taschner H; Kahn RK Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031 [TBL] [Abstract][Full Text] [Related]
13. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus]. Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI. Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656 [TBL] [Abstract][Full Text] [Related]
15. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity. Fridland A Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707 [TBL] [Abstract][Full Text] [Related]
16. Relative cytotoxicity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosyladenine 5'-monophosphate. Juranka P; Chan VL Cancer Res; 1980 Nov; 40(11):4123-6. PubMed ID: 6162544 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin. Cass CE; Au-Yeung TH Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. Revankar GR; Huffman JH; Allen LB; Sidwell RW; Robins RK; Tolman RL J Med Chem; 1975 Jul; 18(7):721-6. PubMed ID: 1171242 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. LePage GA; Worth LS; Kimball AP Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine. Allen LB; Vanderslice LK; Fingal CM; McCright FH; Harris EF; Cook PD Antiviral Res; 1982 Sep; 2(4):203-16. PubMed ID: 6293375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]